根据美国证券交易委员会（SEC）披露的文件，Alpha Tau Medical首席财务官Raphi Levy于6月30日通过公开市场交易，以每股12美元的价格出售了20,000股公司普通股。此次交易由公司高管主动申报，符合相关证券法规对内部人士持股变动的信息披露要求。
根据美国证券交易委员会（SEC）披露的文件，Alpha Tau Medical首席财务官Raphi Levy于6月30日通过公开市场交易，以每股12美元的价格出售了20,000股公司普通股。此次交易由公司高管主动申报，符合相关证券法规对内部人士持股变动的信息披露要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.